Vivira
- Company typePrivate
- Founded2015
- HeadquartersBerlin, Germany
- Headcount11–50
- GTM typeB2C
- OfferingSoftware
What Vivira does
Vivira Health Lab GmbH, founded in 2015 in Munich and Berlin, develops ViViRA — a prescription digital therapeutic (DiGA) for musculoskeletal conditions, primarily back pain, with additional coverage of knee and hip pain. The core product is a mobile application (iOS and Android) that delivers four personalized daily exercises targeting mobility, stability, and coordination, with weekly progress protocols, monthly movement tests, and adaptive intensity adjustment based on user feedback on pain and difficulty. The app is CE-marked as a Class I medical device under EU MDR 2017/745, permanently listed in the BfArM DiGA directory, and certified to ISO 13485 (quality) and ISO 27001 (information security) — a combination Vivira claims to be the first to achieve among German DiGA manufacturers.
The business model is dual-track: (1) prescription-driven reimbursement, where physicians prescribe ViViRA and patients submit prescriptions to statutory health insurers (all GKV and most private insurers cover it), receiving a 16-digit activation code, with pricing set by the German arbitration body; and (2) direct-to-consumer self-pay subscription at €69/month with a 7-day free trial. Vivira also operates a complimentary prescription submission service that handles reimbursement paperwork on behalf of patients, plus a dedicated healthcare professional portal (Fachkreise) for physician engagement. Distribution combines app store product-led growth with a prescription channel through the German DiGA framework.
The company has trained 200,000+ users, holds category leadership as the most prescribed DiGA for musculoskeletal disorders in Germany (per BARMER Doctor Report 2024), and was founded by Dr. Philip Heimann (current Managing Director) alongside rehabilitation clinic operators Dr. Petra Becker and Fabian Blank. In May 2026, Vivira closed a growth financing round led by IBB Capital and Bonventure, with stated use of funds for therapy portfolio expansion, deeper AI integration, and international expansion beyond Germany. The company employs 11–50 staff.
Vivira firmographics
Firmographics- Name
- Vivira
- Legal name
- Vivira Health Lab GmbH
- Website
- https://vivira.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Vivira industry classification
Industry- Product category
- Digital Therapeutics (Musculoskeletal)
- NAICS
- Other Ambulatory Health Care Services (6219)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
- akta.pro secondary industry
- Assistive Technology, Adaptive Equipment & Home Exercise Program Training In-Home (HSABADAN)
Keywords
Where Vivira is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
Vivira business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Health Insurance Reimbursement: German statutory health insurers (GKV) cover ViViRA costs with physician prescription. All statutory health insurers and most private insurers reimburse. Patients submit prescription or diagnostic proof to their insurer, which provides a 16-digit activation code. The German arbitration body sets the official price.
- Direct Consumer Subscription: Self-paying customers can subscribe for EUR 69.00 per month with automatic monthly renewal. 7-day free trial available. Subscription can be cancelled 24 hours before renewal in app stores.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Health Insurance Covered (Prescription) |
| Subscription | Monthly | Self-Payer Monthly Subscription |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels9 records
Vivira product offering
Product offeringCore offering
Vivira develops and sells ViViRA, a prescription digital therapeutic (DiGA) mobile application that delivers daily personalized exercise programs for patients with musculoskeletal pain, primarily back pain. The product functions as an alternative or supplement to physiotherapy, with reimbursement by German statutory health insurers when prescribed by a physician, or via a self-pay subscription at EUR 69 per month.
Product overview
Vivira Health Lab GmbH offers ViViRA as its primary product, a Digital Health Application (DiGA) for musculoskeletal conditions. The core offering is the ViViRA mobile app, which provides guided therapeutic exercise programs for back pain. The product portfolio includes the main app distributed via iOS and Android platforms, a prescription service (Rezept-Service) that helps patients submit e-prescriptions to health insurers, a help center for user support, and a dedicated portal for healthcare professionals. The app is prescribed by physicians and reimbursed by statutory health insurance in Germany, or available via self-pay subscription at €69/month.
Differentiator
Problem solved
Functional benefit
Products and services
- ViViRA (Digital Therapeutic App) A prescription digital therapeutic application (DiGA) for musculoskeletal conditions, providing guided daily therapeutic exercise programs for back, knee, and hip pain. Delivers four daily exercises targeting mobility, stability, and coordination, adapts to user feedback, tracks progress via weekly protocols and monthly movement tests, and is CE-certified as a Class I medical device for adult patients with musculoskeletal disorders in Germany.
Quantifiable outcome
- 53% average pain reduction over 12 weeks compared to 15% for conventional physiotherapy
- +2 more outcomes
Companies that use Vivira
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Vivira technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability4 records
Feature4 records
Vivira partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- CMX Remote GmbHminorService center partner handling inbound/outbound calls, faxes, and emails for customer and prospect communications.
Scale indicators3 records
Recent moves5 records
Expansion highlights6 records
Vivira competitors and assessment
Company assessmentDirect peers
- SWORD Health: Digital MSK therapy combining an app with connected hardware, sold primarily to employers and health plans. Competes for the same patient population and clinician-prescribed digital therapy budgets as Vivira.
- Caspar Health: Berlin-based digital rehabilitation platform combining tele-rehab with prescribed therapeutic exercises for MSK and neurological conditions. Direct peer in German digital rehab, often reimbursed by German payers.
- Kaia Health: Digital therapeutic for musculoskeletal pain (back, knee, hip) delivered via mobile app, with both B2C and B2B channels. Direct competitor in the MSK digital therapeutics category where Vivira competes, including overlap in the German DTx market.
- Selfapy: Berlin-based digital therapeutics company offering DiGA-listed apps (mental health, etc.) via the same German reimbursement framework as Vivira. Same DiGA go-to-market and regulatory model; competes for physician prescribing share and insurer mindshare.
Emerging players
- Temedica: Munich-based digital health company building condition-specific companion apps and real-world evidence platforms. Comparable in being a Munich-based health-software company pursuing regulated digital health products in Germany.
- Sidekick Health: Nordic digital therapeutics company addressing chronic conditions (cardio-metabolic, MSK adjacent) via app-based care. Comparable in business model (prescription/sponsor-funded DTx) and category ambition.
- Perfood: German digital therapeutics company (e.g., sinCephalea migraine DiGA) operating under the same DiGA framework as Vivira. Competes for BfArM-listed DTx status and statutory health insurer reimbursement.
Broad incumbents
- Hinge Health: Largest US-based digital MSK care provider offering app-based exercise therapy, often with wearable sensors, sold to employers and payers. Competes for MSK digital therapy demand globally and increasingly in Europe.
Regional players
- Wellster Healthtech Group: Munich-based digital health platform offering tele-medicine and prescription digital health products to German consumers. Comparable as a German digital health distribution and care-delivery platform.
- Oviva: Europe-based digital therapeutic for diet-related and metabolic conditions (including DiGA-listed products in Germany) sold to insurers and patients. Comparable as a European DTx scaling through reimbursed, app-based care pathways.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Vivira social profiles
Digital presenceVivira compliance and trust
Trust signalCompliance7 records
Vivira financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vivira leadership team
Management profileNumber of profiles
Profiles3 records
Vivira funding detail
Funding detailFunding overview
Funding rounds2 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vivira M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vivira
What does Vivira do?
Vivira develops and sells ViViRA, a prescription digital therapeutic (DiGA) mobile application that delivers daily personalized exercise programs for patients with musculoskeletal pain, primarily back pain. The product functions as an alternative or supplement to physiotherapy, with reimbursement by German statutory health insurers when prescribed by a physician, or via a self-pay subscription at EUR 69 per month.
Is Vivira a public or private company?
Vivira is a private company. It is classified as venture growth investor backed and is currently operating.
When was Vivira founded?
Vivira was founded in 2015. It employs 11 to 50 people.
Where is Vivira based?
Vivira is headquartered in Berlin, Germany, in the Europe region.
How does Vivira make money?
Two revenue lines are on record. Health Insurance Reimbursement is the primary driver. The others are direct Consumer Subscription.
Who are Vivira's main competitors?
Direct peers on record are SWORD Health, Caspar Health, Kaia Health and Selfapy. Emerging players are Temedica, Sidekick Health and Perfood. Hinge Health is listed as a broad incumbent. Regional players are Wellster Healthtech Group and Oviva.
Does Vivira have an API?
No public API is recorded for Vivira.
What industry is Vivira in?
Vivira's product category is Digital Therapeutics (Musculoskeletal). Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs), with a secondary code of HSABADAN, Assistive Technology, Adaptive Equipment & Home Exercise Program Training In-Home. Its NAICS code is 6219 and its SIC code is 7372.